Abstract
The review provides information about the oxygen saturation screening in newborns, basic aims and objectives of this diagnostic
method, the importance of early diagnosis of congenital heart disease in infants during the early neonatal period. Analysis of several
recent studies was carried out, in which presents data on the sensitivity and specificity of the method. Moreover, analysis of the benefits of a later pulse oximetry screening in newborn infants was made. The special attention given to the technical aspects of the diagnostic test as a screening method, the frequency of false-positive and false-negative results and ways to reduce them. Actuality and
importance of using screening saturation in newborns as a method of reducing infant mortality are shown.
References
- Стародубов В.И., Суханова Л.П. Репродуктивные проблемы
демографического развития России. М.: ИД «Менеджер
здравоохранения»; 2012: 320.
- ВолодинН.Н. (ред.) Неонатология: национальное руководство.
М.: ГЭОТАР-Медиа; 2009: 848.
- Неонатальный скрининг с целью выявления критических
врожденных пороков сердца: методические рекомендации
(№ 12). Сост.: М.А. Школьникова, Е.Л. Бокерия, Е.А. Дегтярева,
В.Н. Ильин, Е.С. Шарыкин. М.: ООО «М-Арт»; 2012:
36.
- Roberts T.E., Barton P.M., Auguste P.E., Middleton L.J.,
Furmston A.T., Ewer A.K. Pulse oximetry as a screening test
for congenital heart defects in newborn infants: a cost-effectiveness analysis. Arch Dis Child. 2012; 97 (3): 221-6. DOI:
10.1136/archdischild-2011-300564.
- Zuppa A.A., Riccardi R., Catenazzi P., DAndrea V.,
Cavani M., D'Antuono A., Lafisco A., Romagnoli C. Clinical
examination and pulse oximetry as screening for congenital
heart disease in low-risk newborn. J. Matern. Fetal. Neonatal.
Med. 2015; 28: 7-11.
- Dolk H., Loane M., Garne E., and a European Surveillance of
Congenital Anomalies (EUROCAT) Working Group.
Congenital Heart Defects in Europe Prevalence and Perinatal
Mortality, 2000 to 2005. Circulation. 2011; 123: 841-9.
- Rossier M.C., Mivelaz Y., Addor M.C., Sekarski N., Meijboom
E.J., Vial Y. Evaluation of prenatal diagnosis of congenital heart disease in a regional controlled case study. Swiss
Med. Wkly. 2014; 144: w14068.
- Сенаторова А.С., Гончарь М.А., Пугачёва Е.А. Роль пульсоксиметрии как скринингового метода выявления кардиальной патологии у новорожденных. Современная кардиология
и кардиохирургия - путь от проблем к решению:
материалы научно-практической конференции с международным
участием, посвященной памяти кардиохирурга
Л.Н. Сидоренко (Судак, 7-8 октября 2013 г.). Судак; 2013:
246.
- Eckersley L . , Sadler L . , Parry E., Finucane K., Gentles T.L.
Timing of diagnosis affects mortality in critical congenital heart
disease. Arch Dis Child. 2015. PII: archdischild-2014-
307691. DOI: 10.1136/archdischild-2014-307691.
- Kemper A.R., Mahle W.T., Martin G.R., Cooley W.C.,
Kumar P., Morrow W.R., Kelm K., Pearson G.D., Glidewell J.,
Grosse S.D., Howell R.R. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 2011; 128:
1259-67.
- Mahle W.T., Newburger J.W., Matherne G.P., Smith F.C.,
Hoke T.R., Koppel R., Gidding S.S., Beekman R.H., III,
Grosse S.D. Role of pulse oximetry in examining newborns for
congenital heart disease: a scientific statement from the AHA
and AAP. Pediatrics. 2009; 124: 823-36.
- Acharya G., SitrasV., Maltau J.M., Dahl L.B., Kaaresen P.I.,
Hanssen T.A., Lunde P. Major congenital heart disease in
Northern Norway: shortcomings of pre- and postnatal diagnosis. Acta Obstet. Gynecol. Scand. 2004; 83: 1124-9.
- HunterS., Heads A., Wyllie J., Robson S. Prenatal diagnosis of
congenital heart disease in the northern region of England:
benefits of a training programme for obstetric ultrasonographers.
Heart. 2000; 84: 294-8.
- Westin M., Saltvedt S., Bergman G., Kublickas M., Almstrom
H., Grunewald C., Valentin L. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of
major congenital heart malformations? A randomised controlled trial comprising 36,299 fetuses. BJOG. 2006; 113:
675-82.
- Van Velzen C., Clur S., Rijlaarsdam M., Bax C., Pajkrt E.,
Heymans M., Bekker M., Hruda J., de Groot C., Blom N.,
Haak M. Prenatal detection of congenital heart disease-results
of a national screening programme. BJOG. 2015. DOI:
10.1111/1471-0528.13274.
- Антонов А.Г., Рындин А.Ю. Транскутанный мониторинг
газов крови: клиническое руководство. Под ред. Е.Н. Байбариной. М.; 2010: 24.
- Bickler P.E., Feiner J.R., Severinghaus J.W. Effects of skin
pigmentation on pulse oximeter accuracy at low saturation.
Anesthesiology. 2005; 102: 715-9.
- Ewer A.K. Evidence for CCHD screening and its practical
application using pulse oximetry. Early Hum. Dev. 2014; 90
(Suppl. 2): 19-21. DOI: 10.1016/S0378-3782(14)50006-0.
- Richmond S., Reay G., Abu Harb M. Routine pulse oximetry in
the asymptomatic newborn. Arch Dis. Child. Fetal. Neonatal.
Ed. 2002; 87: 83-8.
- Sendelbach D.M., Lai S., Jackson G.J., Fixler D., Stehel E.K.,
Engle W.D. Pulse oximetry (POx) screening of term and late
preterm neonates at 4 hours postnatal (PN) to detect cyanotic
congenital heart disease (CCHD). Presented at: Pediatric
Academic Societics; Honolulu, Hawaii; May 2-6, 2008.
Abstract E-PAS2008:5896.2.
- US Preventive Services Task Force. Universal screening for
hearing loss in newborns: US Preventive Services Task Force
recommendation statement. Pediatrics. 2008; 122 (1):
143-8.
- Mahle W.T., Martin G.R., Beekman R.H., III, Morrow W.R., Rosenthal
G.L., Snyder C.S., Minich L.L., Mital S., Towbin J.A.,
Tweddell J.S. Endorsement of health and human services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2012; 129: 190-3.
- Ramjattan K., Allen P.J. Pulse oximetry screening for critical
congenital heart disease in the newborn. Pediatr. Nurs. 2013;
39 (5): 250-3.
- Lundsgaard C., Van Slyke D.D. Cyanosis. Medicine. 1923;
(2): 1-76.
- Lees M.H. Cyanosis of the newborn infant: recognition and
clinical evaluation. J. Pediatr. 1970; 77: 484-98.
- Ainsworth S., Wyllie J.P., Wren C. Prevalence and clinical significance of cardiac murmurs in neonates. Arch. Dis. Child.
Fetal. Neonatal. Ed. 1999; 80: 43-5.
- Patton C., Hey E. How effectively can clinical examination pick
up congenital heart disease at birth? Arch. Dis. Child. Fetal.
Neonatal. Ed. 2006; 91: 263-7.
- Reich J.D., Miller S., Brogdon B., Casatelli J., Gompf T.C.,
Huhta J.C., Sullivan K. The use of pulse oximetry to detect
congenital heart disease. J. Pediatr. 2003; 142: 268-72.
- De Wahl Granelli A., Wennergren M., Sandberg K. et al.
1mpact of pulse-oximetry screening on the detection of ductdependent
congenital heart disease: a Swedish prospective
screening study in 39,821 newborns. BMJ. 2009; 338: a3037.
- Riede F.T., Worner C., Ddhnert I., Meckel A., Kostelka M.,
Schneider P. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily
clinical routine: results from a prospective multicenter study.
Eur. J. Pediatr. 2010; 169 (8): 975-81.
- Zhao Q., Ma X., Ge X, Liu F., Yan W., Wu L . , Ye M., Liang X.,
Zhang J., Gao Y., Jia B., Huang G. The neonatal congenital
heart disease screening group. Pulse oximetry with clinical
assessment to screen for congenital heart disease in neonates
in china: a prospective study. Lancet. 2014; 384: 747-54.
- Hoke T.R., DonohueP.K., BawaP.K., MitchellR.D., Pathak A.,
Rowe P.C., Byrne B.J. Oxygen saturation as screening test for
critical congenital heart disease: a preliminary study. Pediatr.
Cardiol. 2002; 23: 403-9.
- De Wahl Granelli A., MellanderM., Sunnegardh J., Sandberg
K., Ostman-Smith I. Screening for duct-dependant congenital heart disease with pulse oximetry: a critical evaluation
of strategies to maximize sensitivity. Acta Paediatr. 2005; 94:
1590-6.
- Meberg A., Brugmann-Pieper S., Due R., Jr., Eskedal L . ,
Fagerli I., Farstad T., Froisland D.H., Sannes C.H., Johansen
O.J., Keljalic J., Markestad T., Nygaard E.A., Rosvik A.,
Silberg I.E. First day of life pulse oximetry screening to detect
congenital heart defects [published correction appears in J.
Pediatr. 2009; 154: 629]. J. Pediatr. 2008; 152: 761-5.
- Johnson L.C., Lieberman E., O'Leary E., Geggel R.L. Prenatal
and newborn screening for critical congenital heart disease:
findings from a nursery. Pediatrics. 2014; 134 (5): 916-22.
DO1: 10.1542/peds.2014-1461.
- Therell B., Lorey F., Eaton R. et al. 1mpact of expanded newborn screening: United States, 2006. MMWR Morb. Mortal.
Wkly. Rep. 2008; 57 (37): 1012-5.
- Lhost J.J., GoetzE.M., Belling J.D., van Roojen W.M., SpicerG.,
Hokanson J.S. Pulse oximetry screening for critical congenital
heart disease in planned out-of-hospital births. J. Pediatr.
2014; 165 (3): 485-9. DO1: 10.1016/j.jpeds.2014.05.011.
- Карпова А.Л., Спивак Е.М., Пыханцева А.Н. Диагностическое значение определения величины сатурации кислорода у доношенных новорожденных. Пермский медицинскийжурнал. 2014; 33 (5): 6-10.
- Levesque B.M., Pollack P., Griffin B.E., Nielsen H.C. Pulse
oximetry: what's normal in the newborn nursery? Pediatr.
Pulmonol. 2000; 30: 406-12.
- Kemper A.R., Knapp A.A., Metterville D.R., Comeau A.M.,
Green N.S., Perrin J.M. Weighing the evidence for newborn
screening for hemoglobin H disease. J. Pediatr. 2011; 158 (5):
780-3.
- Barker S.J. «Motion-Resistant» pulse oximetry: a comparison
of new and old models. Anesth. Analg. 2002; 95 (4): 967-72.
- Malviya S., Reynolds P.I., Voepel-Lewis T., Siewert M.,
Watson D., Tait A.R., TremperK. False alarms and sensitivity of
conventional pulse oximetry versus the masimo set technology in the pediatric postanesthesia care unit. Anesth. Analg.
2000; 90 (6): 1336-40.
- Baquero H., Alviz R., Castillo A., Neira F., Sola A. Avoiding
hyperoxemia during neonatal resuscitation: time to response
of different SpO2 monitors. Acta Paediatr. 2011; 100 (4):
515-8.
- Ozalkaya E., Akdag A., Sen I., Comert E., Melek Yaren H.
Early screening for critical congenital heart defects in asymptomatic newborns in Bursa province. J. Matern. Fetal.
Neonatal. Med. 2015; 22: 1-3.
